1Department of Biology, Faculty of Science and Technology, Universitas Airlangga, Surabaya, Indonesia
10Medical and Biological Faculty, North Caucasus Federal University, Stavropol, RussiaRussian Federation
11Department of Scientific Research, V. M. Gorbatov Federal Research Center for Food Systems, Moscow, RussiaRussian Federation
12Faculty of Biotechnology and Food Engineering, Ural State Agrarian University, Yekaterinburg, RussiaRussian Federation
13Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India
2Computational Virology Research Unit Division of Molecular Biology and Genetics, Generasi Biologi Indonesia Foundation, Gresik, Indonesia
3Professor Nidom Foundation, Surabaya, Indonesia
4Department of Orthodontics, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
5Pharmacy Department Faculty of Science and Technology, Ma Chung University, Malang, Indonesia
6Department of Nanotechnology Engineering, Faculty of Advance Technology and Multidiscipline, Universitas Airlangga, Surabaya, Indonesia
7Faculty of Dentistry, Stavropol State Medical University, Stavropol, RussiaRussian Federation
8Medical and Preventive Faculty, Rostov State Medical University, Rostov-on-Don, RussiaRussian Federation
9Faculty of Medicine, Stavropol State Medical University, Stavropol, RussiaRussian Federation
*Corresponding Author E-mail: dwi-k-w@fst.unair.ac.id
Online published on 13 June, 2024.
Viral replication inhibition strategies are needed to prevent pandemics through the latest therapeutic agent designs. A viral infection occurring over a wide area is called a pandemic. The strategy of inhibiting virus replication is used to tackle the pandemic Viruses can trigger negative regulation of apoptosis in host cells for viral survival. Apoptosis can reduce viral load and inhibit viral replication. Several types of viruses can evade the immune response through upregulation of various anti-apoptotic proteins, which allows this research to explore specific types of anti-apoptotic proteins in host cells for the design of candidate therapeutic agents.Medicinal plants from the Dayak Lundayeh tribe in North Kalimantan have potential for health, the antiviral potential of these plants has not been identified. This study aims to reveal the potential of the bioactive compounds from Bawang Ada' as antivirals with a molecular mechanism through apoptosis with an in silico approach.The in silico method used in this study consisted of ligand preparation, druglikeness analysis, pathway prediction, docking, and molecular interaction.Bawang Ada' acts as the best antiviral candidate through the activity of Erythrolaccin and Isoeleutherin compounds in inhibiting antiapoptotic proteins consisting of GSK3B and AKT1. We recommend the binding sites Val70, Leu132, Ile62, Leu188, Asp200, and Cys199 (GSK3B) and Leu210, Leu264, Tyr272, Asp292, Trp80, Lys 268, Val270, and Ser205 (AKT1) for further research as antiviral target development.
Apoptosis Agonist, Antiviral, Bawang Ada’, Bioinformatics, Eleutherine americana